pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·8h ago·1 min read
save

FDA nominee Heidi Overton affirms safety of vaccines and mifepristone in Senate hearing

Sep 24, 2026·read at Fierce Biotech ↗RegulatoryNeutral

Heidi Overton, the Trump administration’s pick for FDA commissioner, appeared before the Senate Health, Education, Labor and Pensions Committee to answer questions about her views on key public‑health issues.

During the hearing Overton repeatedly stated that vaccines approved by the FDA and the medication mifepristone are both safe and effective, while avoiding any admission that the President had provided inaccurate medical information.

Committee Chairman Bill Cassidy pressed Overton on vaccine policy and the administration’s promises on vaccine access, highlighting the political sensitivity of the topic.

The committee will now vote on whether to forward Overton’s nomination to the full Senate for confirmation, as she also emphasized the need to accelerate drug development to stay competitive with China.

source

This writeup was produced by pharmadog from original reporting by Fierce Biotech.

Original headline: “Trump's FDA pick Heidi Overton calls vaccines, mifepristone safe and effective in confirmation hearing”

read at Fierce Biotech ↗
1,220 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

drugs
MIFEPRISTONE13ACETAMINOPHEN AND IBUPROFEN2HYDROCODONE BITARTRATE AND ACETAMINOPHEN2OXYCODONE AND ACETAMINOPHEN2
topics
Vaccines10Vaccine9AdComApproval

related stories

  • Sep 17Kennedy announces new effort to speed up autism diagnosesSTAT
  • 4h agoUS senators grill FDA nominee Overton on ability to ‘stand up’ to TrumpBioSpace
  • Sep 17ARPA-H launches SPECTRA program, new autism research initiativeFierce Biotech
  • Apr 30STAT+: In her own words: Surgeon general nominee Nicole Saphier expresses enthusiasm and caution for MAHASTAT
  • Sep 14After a brief storm of political headwinds, mRNA is back with strong momentumBioSpace